Formulations - Exports of Finished Formulations

Formulations - Oncology

1Abiraterone Acetate Tablets 250mgTERONISH 250
2Bendamustin Hydrochloride Injection 100mgBENDANISH 100
3Bortezomib Injection 2mg/2ml BORTENISH 2 mg
4Bortezomib Injection 3.5mg/3.5ml BORTENISH 3.5 mg
5Capecitabine Tablets 500mgCAPENISH 500
6Carboplatin Injection 150mg/15mlCARBONISH 150
7Carboplatin Injection 450mg/45mlCARBONISH 450
8Cisplatin Injection 10mg/20mlCHEMOTIN 10
9Cisplatin Injection 50mg/50mlCHEMOTIN 50
10Dacarbazine HCL Injection 200mgBaziNish 200
11Docetaxel Injection 20mg/0.5ml DOCENISH 20
12Docetaxel Injection 80mg/2ml DOCENISH 80
13Doxorubicin Injection 10mg/5mlDOXOL 10
14Doxorubicin Injection 50mg/25mlDOXOL 50
15Epirubicin Injection 10mg/5mlEPINISH 10
16Epirubicin Injection 50mg/25mlEPINISH 50
17Erlotinib Tablets 100mgERLONISH 100
18Erlotinib Tablets 150mgERLONISH 150
19Gefitinib Tablets 250mgGEFINISH 250
20Gemcitabine Injection 1000mg/50mlGEMENISH 1000
21Gemcitabine Injection 200mg/10mlGEMENISH 200
22Imatinib Tablets 400mg IMATOL 400
23Oxaliplatin Injection 50mg/25mlOXANOL 50
24Oxaliplatin Injection 100mg/50mlOXANOL 100
25Paclitaxel Injection 100mg/16.67mlPaxol 100
26Paclitaxel Injection 260mg/43.4mlPaxol 260
27Paclitaxel Injection 30mg/5mlPaxol 30
28Zolendronic Acid Lypholized Injection 4mgGeneric
29Anastrazole Tablets 1mg Generic
30Aprepitant Capsules 80mg / 125mg Generic
31Biclutamide Tablets 50mgGeneric
32Bleomycin 15000IU LypholizedGeneric
33Cyclophosphamide 500mg / 1gGeneric
34Cyclophosphamide Tablets 50mgGeneric
35Cyterabine 100mg / 1gGeneric
36Flutamide Tablets 250mgGeneric
37Fosaaprepitant 150mg Lypholized Generic
38Hydroxy Urea Tablets 500mgGeneric
39Idarudicin 20mg LypholizedGeneric
40Lapatinib Tablets Generic
41Lenalidomide Tablets 50mg / 100mg / 250mgGeneric
42Methotrexate Tablets 2.5mg / 5mg / 10mgGeneric
43Paclitaxel Albumin Bound 100mg Lypholized Generic
44Pemetrexed 100mg / 500mg LypholizedGeneric
45Sorafinib Tablets Generic
46Sunitinib Tablets Generic

Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Also the onus of patent applicability shall remain with importer only.